StephenMichaelGollompMD

PubMed

• 1 citations
  A Narrative Literature Review of the Established Safety of Human Serum Albumin Use as a Stabilizer in Aesthetic Botulinum Toxin Formulations Compared to Alternatives.
  Sonja Sattler, Stephen Gollomp, Andrew Curry> ;Toxins. 2023 Oct 18
• Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience.
  Parashos SA, Luo S, Biglan KM, Bodis-Wollner I, He B, Liang GS, Ross GW, Tilley BC, Shulman LM, NET-PD Investigators> ;JAMA neurology.
• Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson'...
  Elm JJ, NINDS NET-PD Investigators> ;Movement disorders : official journal of the Movement Disorder Society.
• Efficacy, tolerability, and immunogenicity of onabotulinumtoxina in a randomized, double-blind, placebo-controlled trial for cervical dystonia.
  Charles D, Brashear A, Hauser RA, Li HI, Boo LM, Brin MF, CD 140 Study Group> ;Clinical neuropharmacology.
• Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.
  Pankratz N, Beecham GW, DeStefano AL, Dawson TM, Doheny KF, Factor SA, Hamza TH, Hung AY, Hyman BT, Ivinson AJ, Krainc D, Latourelle JC, Clark LN, Marder K, Martin ER,...> ;Annals of neurology.
• 38 citations
  GM1 ganglioside in Parkinson's disease: Pilot study of effects on dopamine transporter binding
  Jay S. Schneider, Franca Cambi, Stephen Gollomp, Hiroto Kuwabara, James Robert Brašić, Benjamin E. Leiby, Stephanie Sendek, Dean F. Wong> ;Journal of the Neurological Sciences. 2015 Sep 15
• 40 citations
  Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin®) injections in blepharospasm
  Daniel D. Truong, Stephen Gollomp, Joseph Jankovic, Peter A LeWitt, Michael W. Marx, Angelika Hanschmann, Hubert H. Fernandez> ;Journal of Neural Transmission. 2013 Feb 23
• 107 citations
  A Randomized, Controlled, Delayed Start Trial of GM1 Ganglioside in Treated Parkinson’s Disease Patients
  Jay S. Schneider, Stephen Gollomp, Stephanie Sendek, Amy Colcher, Franca Cambi, Wei Du> ;Journal of the Neurological Sciences. 2013 Jan 15
• Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN®, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia.
  Comella CL, Jankovic J, Truong DD, Hanschmann A, Grafe S, U.S. XEOMIN Cervical Dystonia Study Group> ;Journal of the neurological sciences. 2011-07-18
• Impact of belief in neuroprotection on therapeutic intervention in Parkinson's disease.
  Elble, R. J., Suchowersky, O., Shaftman, S., Weiner, W. J., Huang, P., Tilley, B.> ;Mov Disord. 2010 Jun 15
• 19 citations
  Repeatable Battery for Assessment of Neuropsychological Status in Early Parkinson’s Disease
  Chengwu Yang, Elizabeth Garrett-Mayer, Jay S. Schneider, Stephen Gollomp, Barbara C. Tilley> ;Movement Disorders. 2009 Jul 30
• Istradefylline as monotherapy for Parkinson disease: results of the 6002-US-051 trial.
  Fernandez HH, Greeley DR, Zweig RM, Wojcieszek J, Mori A, Sussman NM, 6002-US-051 Study Group> ;Parkinsonism & related disorders. 2009-07-19
• Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease.
  Hauser, R. A., Panisset, M., Abbruzzese, G., Mancione, L., Dronamraju, N., Kakarieka, A.> ;Mov Disord. 2009 Mar 15
• A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results.
  > ;Clin Neuropharmacol. 2008 May-Jun
• 169 citations
  A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease
  Karl Kieburtz, Bernard Ravina, Wendy R. Galpern, Barbara C. Tilley, Kathleen M. Shannon, Caroline M. Tanner, G. Frederick Wooten, Robert W. Hamill, Jacob I. Sage, Emil...> ;Neurology. 2007 Jan 2
• 50 citations
  Bilateral Facial Paralysis: Case Presentation and Discussion of Differential Diagnosis
  Vishal Jain, Anagha Deshmukh, Stephen Gollomp> ;Journal of General Internal Medicine. 2006 Jul 1
• 15 citations
  A pilot study of botulinum toxin A for headache in cervical dystonia.
  William G. Ondo, Stephen Gollomp, Nestor Galvez-Jimenez> ;Headache. 2005 Sep 1
• Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies.
  Duda, J. E., Giasson, B. I., Chen, Q., Gur, T. L., Hurtig, H. I., Stern, M. B., Gollomp, S. M., Ischiropoulos, H., Lee, V. M., Trojanowski, J. Q.> ;Am J Pathol. 2000 Nov
• Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy.
  Duda, J. E., Giasson, B. I., Gur, T. L., Montine, T. J., Robertson, D., Biaggioni, I., Hurtig, H. I., Stern, M. B., Gollomp, S. M., Grossman, M., Lee, V. M., Trojanows...> ;J Neuropathol Exp Neurol. 2000 Sep
• Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease.
  Hurtig, H. I., Trojanowski, J. Q., Galvin, J., Ewbank, D., Schmidt, M. L., Lee, V. M., Clark, C. M., Glosser, G., Stern, M. B., Gollomp, S. M., Arnold, S. E.> ;Neurology. 2000 May 23
• 112 citations
  Stereotactic radiosurgical pallidotomy and thalamotomy with the gamma knife: MR imaging findings with clinical correlation--preliminary experience.
  David Friedman, H W Goldman, Adam E. Flanders, Stephen Gollomp, Curran Wj> ;Radiology. 1999 Jul 1
• Olfactory function in Parkinson's disease subtypes.
  Stern, M. B., Doty, R. L., Dotti, M., Corcoran, P., Crawford, D., McKeown, D. A., Adler, C., Gollomp, S., Hurtig, H.> ;Neurology. 1994 Feb
• 37 citations
  Cognitive and physiological substrates of impaired sentence processing in parkinson's disease
  Murray Grossman, Susan Carvell, Stephen Gollomp, Matthew B. Stern, Martin Reivich, Donald F. Morrison, Abass Alavi, Howard I. Hurtig> ;Journal of Cognitive Neuroscience. 1993 Oct 1
• 86 citations
  Sentence comprehension in Parkinson's disease: the role of attention and memory.
  Murray Grossman, Susan Carvell, Matthew B. Stern, Stephen Gollomp, Howard I. Hurtig> ;Brain and Language. 1992 May 1
• Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson''s disease.
  Doty, R. L., Stern, M. B., Pfeiffer, C., Gollomp, S. M., Hurtig, H. I.> ;J Neurol Neurosurg Psychiatr. 1992 Feb
• Join now to see all

Journal Articles

• Creatine Does Not Slow Rate of Parkinson Disease Progression  
  NET-PD Investigators, JAMA Neurol, 1/1/2015
• Measuring Disease Progression in Early Parkinson Disease The National Institutes of Health Exploratory  
  Sotirios A. Parashos, MD, PhD; Sheng Luo, MS; Kevin M. Biglan, MD, MPH; Ivan Bodis-Wollner,MD, DSc; Bo He, MS; Grace S. Liang, MD; G. Webster Ross, MD; Barbara C. Till..., JAMA Neurol, 1/1/2014
• A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson�s disease patients  
  Schneider, J.S., Gollomp, S.M., Sendek, S., Colcher, A., Cambi, F., and Du, W, J Neurol. Sci., 1/1/2013
• Sustained efficacy and safety of repeated incobotulinumA (Xeomin)injections in blepharospasm  
  Truong DD, Gollomp SM, Jankovic J, LeWitt PA, Marx M, Hanschmann A, Fernandez HH; Xeomin US Blepharospasm Study Group, J Neural Transm, 1/1/2013
• Repeatable battery for assessment of neuropsychological status in early Parkinson's disease  
  Yang, C., Garrett-Mayer, E., Schneider, J. S., Gollomp, S. M. and Tilley, B. C., Movement Disorders, 1/1/2009
• A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson�s disease  
  NINDS NET-PD Investigators, Neuorology, 1/1/2007
• Prevalence of headache attributed to craniocervical dystonia: An epidemiologic study  
  Molho E, Lipton RB, Bigal ME, Gollomp S, Felix C, VanDenburgh AM, Brin MF for the Headache in CD Study Group, Headache, 1/1/2006
• Hemifacial Spasm associated with Acoustic Neuroma and Tortuous Vertebral Artery  
  Kim, M, Gollomp, SM, Movement Disorders, 1/1/2006
• A randomized, multicenter, double-blind, placebo-controlled study of botulinum toxin type A (Botox) for the treatment of cervical dystonia  
  Brin, M, and Botox 140 Study Group, Neurology, 1/1/2006
• A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease  
  NINDS NET-PD Investigators, Neuorology, 1/1/2006
• Optimizing the ongoing search for new treatments for Parkinson disease: Using futility designs  
  B. C. Tilley, Y. Y. Palesch, K. Kieburtz, B. Ravina, P. Huang, J. J. Elm, K. Shannon, G. F. Wooten, C. M. Tanner, G. C. Goetz on behalf of the NET-PD Investigators, Neurology, 1/1/2006
• Dystonia and Headache: The response to botulinum toxin type A therapy  
  Ondo, WG, Galvez-Jimenez, N, Gollomp, SM, Headache, 1/1/2004
• Emergence of complex, involuntary movements after Gamma Knife radiosurgery for essential tremor  
  Siderowf, AD, Gollomp, SM, Stern, MB, Baltuch, GH, Riina, HA, Movement Disorders, 1/1/2001
• Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson�s disease  
  Hurtig, HI, Trojanowski, JQ, Galvin, J, Ewbank, D, Schmidt, ML, Lee, VM-Y, Clark, CM, Glosser, G, Stern, MB, Gollomp, SM, Arnold, SE, Neurology, 1/1/2000
• Immunohistochemical and biochemical studies demonstrate a distinct profile of a-synuclein permutations in multiple system atrophy  
  Duda, JE, Giasson, BI, Gur, TL, Montine, TJ, Robertson, D, Biaggioni, I, Hurtig, HI, Stern, MB, Gollomp SM, Grossman, M, Lee, VM-Y, Trojanowski, JQ, J Neuropath Exper Neurol, 1/1/2000
• Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy  
  Duda JE, Giasson BI, Gur TL, Montine TJ, Robertson D, Biaggioni I, Hurtig HI, Stern MB, Gollomp SM, Grossman M, Lee VM, Trojanowski JQ, Journal of Neuropathology & Experimental Neurology, 1/1/2000
• Binding of [Tc-99m]TRODAT-1 to dopamine transporters in patients with Parkinson�s disease and healthy volunteers  
  Mozley, PD, Schneider, JS, Acton, PD, Barraclough, ED, Stern, MB, Leopold, NA, Plossl, K, Siderowf, A, Li, PY, Gollomp, SM, Alavi, A, Kung, HF, J. Nucl. Med., 1/1/2000
• Stereotactic radiosurgical pallidotomy and thalomotomy with the Gamma Knife: MR imaging findings with clinical correlation-preliminary experience  
  Friedman, D, Goldman, HW, Flanders, A, Gollomp, SM, Curran, WJ, Radiology, 1/1/1999
• Handbook of Dystonia: Volume 39-Neurological Disease and Therapy Series  
  Gollomp, SM., Neurosurgery, 1/1/1997
• Etiology of Parkinson�s Disease: Volume 40-Neurological Disease & Therapy Series  
  Gollomp, SM., Neurosurgery, 1/1/1996
• Verbal fluency deficits in parkinson's disease  
  Auriacombe, S, Grossman, M, Carvell, S, Gollomp, S, Stern, MB, Hurtig, H, Neuropsychology, 1/1/1993
• Sentence comprehension in Parkinson's disease: the role of attention and memory  
  Grossman, M., Carvell, S., Stern, M., Gollomp, S., Hurtig, H., Brain and Language, 1/1/1992
• Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease  
  Doty, RL, Stern, MB, Pfeiffer, C, Gollomp, SM, and Hurtig, HI., J Neurol Neurosurg Psychiatry, 1/1/1992
• Sentence comprehension deficits in Parkinson's disease: The role of the anterior cingulate  
  Grossman, M., Crino, P., Reivich, M., Stern, M.B., Gollomp, S., Hurtig, H.I., Cerebral Cortex, 1/1/1992
• The frequency of dementia in mild Parkinson's disease: statistically-guided analyses of individual patient performance profiles  
  Grossman, M., Carvell, S., Stern, M., Gollomp, S., Vernon, G., Hurtig, H., Movement Disorders, 1/1/1991
• Join now to see all

Books/Book Chapters

• Neurology of the Lower Extremities 
  Chapter: Movement Disorders of the Lower Extremities 
  Gollomp, SM.Editors: Mandel, S., McCluskey, L., and Willis, J..Churchill Livingstone, New York1999
• Understanding Sleep: The Evaluation and Treatment of Sleep Disorders 
  Chapter: Sleep and Sleep Disorders in Noncardiopulmonary Medical Disorders 
  Pressman, MR, Gollomp, S, Benz, RL, and Peterson, DD.Editors: Pressman, MR. and Orr, WC..American Psychological Association, Washington, DC1997
• Practical Neurology of the Elderly 
  Chapter: Atypical Parkinsonisms 
  Gollomp, SM, Stern, MBEditors: Sage, JI. and Mark, M..Marcel Dekker, New York1996
• Parkinsonian Syndromes 
  Chapter: Rigid Variant of Huntington's Disease 
  Gollomp, SM.Editors: Stern, M. and Koller, W..v, New York1993
• Experimental Therapeutics of Movement Disorders 
  Chapter: Therapeutic Trials in Meige Syndrome 
  Gollomp, S.M., Burke, R.E., Reches, A., Ilson, J. and Fahn, S.Editors: Shoulson, I., Fahn, S., and Calne, D..Raven Press, New York1983
• Join now to see all

Abstracts/Posters

• Clinical and neuroimaging outcomes up to 18 years after fetal tissue transplant for Parkinson�s disease
  Henchcliffe, C, Carter, J, Hanineva, A, Kang, Y, Babich, J, Gollomp, SM, Strafella, AP, Fasano, A, Ravdin, LD, Hellmers, N, Mcrae, C, Movement Disorders, 1/1/2016
• Clinical experiences with botulinum toxin type B (Myobloc) in the treatement of cervical dystonia: secondary resistance and electrophysiologic observations
  Gollomp SM, Annals of Neurology, 1/1/2003
• Paraneoplastic myelopathy secondary to adenocarcinoma of the lung
  Kim, M, Gollomp, SM, Annals of Neurology, 1/1/2002
• Effects of dopamine replacement on cognitive and motor functions in Parkinson�s disease: Correlation with [Tc-99m]TRODAT-1 labeling of striatal dopamine transporter sites
  Schneider, J.S., Ferraro, S., Gollomp, S.M., Mancall, E.L., Cambi, F., and Mozley, P.D., Soc. Neurosci., 1/1/2001
• Functional outcome after radiosurgery for tremor
  Hughes, SL, Gollomp, SM, Bednarz, G, Werner-Wasik, M, Curran, WJ, Goldman, HW, Proceedings of the 41st Annual ASTRO Meeting, IJROBP, 1/1/1999
• Radiosurgical treatment of essential tremor
  Gollomp SM, Goldman HW, Aita A, McGlinn K, Scanlon J, Neurology, 1/1/1998
• Recurrent life threatening polycythemic chorea successfully treated with metyrosine
  Gollomp SM, Brown, D, Movement Disorders, 1/1/1998
• Results of the combined intradural/extradural rhizotomy/ramisectomy-neurectomy procedure for refractory spasmodic torticollis
  Neff S, Gollomp, S, Movement Disorders, 1/1/1998
• Post-market comparison of controlled release Sinemet and standard Sinemet
  Hurtig HI, Skolnick BE, Matthews MR, Colcher A, Gollomp SM, Stern MB, Movement Disorders, 1/1/1996
• Post market comparison of controlled-release Sinemet (50/200) and standard Sinemet: a six-month follow-up study
  Hurtig HI, Matthew MR, Vernon GM, Colcher A, Sharkey MJ, Gollomp SM, Stern MB, Movement Disorders, 1/1/1994
• Olfactory function in subtypes of Parkinson's Disease
  Dotti M, Stern M, Doty R, Crawford D, Adler C, Gollomp S, and Hurtig H., Neurology, 1/1/1992
• A Case-Control Study of the Genetic Epidemiology of Parkinson's Disease
  Gruber, S., Stern, M., Dulaney, E., Golbe, L., Bergen, M., Hurtig, H., Gollomp, S., and Stolley, P., Movement Disorders, 1/1/1991
• Dopa Responsive, Diurnally Fluctuating, Primary Writing Tremor
  Gollomp, S., Hurtig, H., Stern, M., and Vernon, G., Movement Disorders, 1/1/1990
• The Elusive Nature of Subcortical Dementia: Definition and Clinical Usefulness in Parkinson's Disease
  Grossman, M., Hurtig, H., Stern, M., and Gollomp, S., Movement Disorders, 1/1/1990
• Bilateral Olfactory Dysfunction in Early Stage Medicated and Unmedicated Parkinsonism
  Doty, R., Stern, M., Pfeiffer, C., Gollomp, S., and Hurtig, H., Neurology, 1/1/1990
• Specific Language Impairments in Parkinson's Disease
  Grossman, M., Digby, L., Hurtig, H., Stern, M., and Gollomp, S., Neurology, 1/1/1990
• Correlates of clinical decline in early Parkinson`s Disease
  Parkinson Study Group, Neurology, 1/1/1987
• Is low-dose, slow-increase Bromocriptine effective in Advanced Parkinson's Disease
  Stern, M., Melvin, G., Gollomp, S.M. and Hurtig, H., Neurology, 1/1/1985
• Pharmocotherapy versus Botulinin in the Treatment of Blepharospasm: A preliminary report
  Annals of Neurology, Annals of Neurology, 1/1/1984
• Central Nervous System Whipple's Disease presenting as the Tolosa-Hunt Syndrome: Report of a Case
  Gollomp, S.M., Andersen, R.B. and Dorwart, B., Neurology, 1/1/1982
• Meige Syndrome: A Review of 31 Cases
  Gollomp, S.M., Ilson, J., Burke, R.E., Reches, A. and Fahn, S., Neurology, 1/1/1981
• Tardive Dystonia: A Persistent Dystonia due to Antipsychotic Drugs
  Burke, R.E., Fahn, S., Jankovic, J. and Gollomp, S.M., Neurology, 1/1/1981
• Join now to see all